top
Thursday, April 27, 2017
Purposes: To support high risk/high impact, early discovery research on HIV vaccine approaches; a Go/No-Go approach to funding high risk research significantly different from most R01 projects; and encourage involvement of investigators new to the HIV vaccine field to build interdisciplinary approaches. For more information, click here.